Published in Intensive Care Med on June 28, 2014
Acute respiratory failure in patients with hematological malignancies: outcomes according to initial ventilation strategy. A groupe de recherche respiratoire en réanimation onco-hématologique (Grrr-OH) study. Ann Intensive Care (2015) 0.80
Optimism and no longer foolishness? Haematology/oncology and the PICU. Intensive Care Med (2014) 0.76
Supporting respiratory function in the immunocompromised critically ill patient: new perspectives for an old paradigm. J Thorac Dis (2015) 0.75
Outcomes and Predictors of Mortality for Patients with Acute Leukemia Admitted to the Intensive Care Unit. Can Respir J (2016) 0.75
Acute kidney injury in critically ill cancer patients: an update. Crit Care (2016) 0.75
Improved outcome of critically ill patients with hematological malignancies: what's next? Intensive Care Med (2014) 0.75
Increased mortality in hematological malignancy patients with acute respiratory failure from undetermined etiology: a Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologique (Grrr-OH) study. Ann Intensive Care (2016) 0.75
Body mass index is associated with hospital mortality in critically ill patients: an observational cohort study. Crit Care Med (2013) 6.16
Variation in critical care services across North America and Western Europe. Crit Care Med (2008) 5.00
Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood (2005) 3.10
Routine use of the confusion assessment method for the intensive care unit: a multicenter study. Am J Respir Crit Care Med (2011) 2.97
Delirium in critically ill patients: impact on long-term health-related quality of life and cognitive functioning. Crit Care Med (2012) 2.91
Mechanical ventilation-induced intrathoracic pressure distribution and heart-lung interactions*. Crit Care Med (2014) 2.73
Temporal abstraction for feature extraction: a comparative case study in prediction from intensive care monitoring data. Artif Intell Med (2007) 2.66
Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change? Am J Respir Crit Care Med (2013) 2.65
The association between ICU level of care and mortality in the Netherlands. Intensive Care Med (2015) 2.64
The impact of computerized physician medication order entry in hospitalized patients--a systematic review. Int J Med Inform (2007) 2.59
A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J Clin Invest (2011) 2.52
"Less is more" in critically ill patients: not too intensive. JAMA Intern Med (2013) 2.51
Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients. Clin Infect Dis (2009) 2.49
Evaluation of outpatient computerized physician medication order entry systems: a systematic review. J Am Med Inform Assoc (2007) 2.20
The costs of initial treatment for patients with acute myeloid leukemia in the Netherlands. Leuk Res (2012) 2.18
Gender differences in the innate immune response and vascular reactivity following the administration of endotoxin to human volunteers. Crit Care Med (2007) 2.18
A comparison of the performance of a model based on administrative data and a model based on clinical data: effect of severity of illness on standardized mortality ratios of intensive care units. Crit Care Med (2012) 2.13
A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock (2014) 2.11
In-hospital mortality and long-term survival of patients with acute intoxication admitted to the ICU. Crit Care Med (2014) 2.10
Therapeutic drug monitoring of voriconazole. Ther Drug Monit (2008) 2.09
Incidence and short-term consequences of delirium in critically ill patients: A prospective observational cohort study. Int J Nurs Stud (2011) 2.05
Contribution of various metabolites to the "unmeasured" anions in critically ill patients with metabolic acidosis. Crit Care Med (2008) 1.99
Alkaline phosphatase treatment improves renal function in severe sepsis or septic shock patients. Crit Care Med (2009) 1.93
Impaired renal function is associated with greater urinary strong ion differences in critically ill patients with metabolic acidosis. J Crit Care (2011) 1.90
The impact of hospital and ICU organizational factors on outcome in critically ill patients: results from the Extended Prevalence of Infection in Intensive Care study. Crit Care Med (2015) 1.85
Improving quality of care. A systematic review on how medical registries provide information feedback to health care providers. Int J Med Inform (2010) 1.84
Development of endotoxin tolerance in humans in vivo. Crit Care Med (2009) 1.84
Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study. Int J Antimicrob Agents (2011) 1.80
Paradoxical increase in circulating Aspergillus antigen during treatment with caspofungin in a patient with pulmonary aspergillosis. Clin Infect Dis (2006) 1.79
Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents. Clin Infect Dis (2009) 1.73
Influence of mild therapeutic hypothermia after cardiac arrest on hospital mortality. Crit Care Med (2011) 1.69
Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders. Clin Chem (2010) 1.68
The impact of different prognostic models and their customization on institutional comparison of intensive care units. Crit Care Med (2007) 1.62
Prediction of long-term mortality in ICU patients: model validation and assessing the effect of using in-hospital versus long-term mortality on benchmarking. Intensive Care Med (2013) 1.61
Mortality after hospital discharge in ICU patients. Crit Care Med (2013) 1.60
Differential ex vivo and in vivo endotoxin tolerance kinetics following human endotoxemia. Crit Care Med (2011) 1.59
Effect of a multifaceted performance feedback strategy on length of stay compared with benchmark reports alone: a cluster randomized trial in intensive care*. Crit Care Med (2013) 1.56
F-18-fluorodeoxyglucose positron emission tomography combined with CT in critically ill patients with suspected infection. Intensive Care Med (2009) 1.55
Determinants of mortality after hospital discharge in ICU patients: literature review and Dutch cohort study. Crit Care Med (2013) 1.54
Regulation of hepcidin: insights from biochemical analyses on human serum samples. Blood Cells Mol Dis (2007) 1.51
Guideline implementation results in a decrease of pressure ulcer incidence in critically ill patients. Crit Care Med (2007) 1.49
Combination of biomarkers for the discrimination between bacterial and viral lower respiratory tract infections. J Infect (2012) 1.47
Effectiveness and Clinical Outcomes of a Two-Step Implementation of Conservative Oxygenation Targets in Critically Ill Patients: A Before and After Trial. Crit Care Med (2016) 1.47
Hypercapnic acidosis attenuates the pulmonary innate immune response in ventilated healthy mice. Crit Care Med (2008) 1.45
A systematic review on quality indicators for tight glycaemic control in critically ill patients: need for an unambiguous indicator reference subset. Crit Care (2008) 1.44
The influence of volume and intensive care unit organization on hospital mortality in patients admitted with severe sepsis: a retrospective multicentre cohort study. Crit Care (2007) 1.43
Influence of entry criteria on mortality risk and number of eligible patients in recent studies on severe sepsis. Crit Care Med (2005) 1.43
Functional heterogeneity and differential priming of circulating neutrophils in human experimental endotoxemia. J Leukoc Biol (2010) 1.42
Inflammation-induced hepatotoxicity in humans. Shock (2009) 1.40
Performance of risk-adjusted control charts to monitor in-hospital mortality of intensive care unit patients: a simulation study. Crit Care Med (2012) 1.39
Association between administered oxygen, arterial partial oxygen pressure and mortality in mechanically ventilated intensive care unit patients. Crit Care (2008) 1.39
Inhibition of caspase-1 activation in Gram-negative sepsis and experimental endotoxemia. Crit Care (2011) 1.38
Individual and Clustered Rankability of ICUs According to Case-Mix-Adjusted Mortality. Crit Care Med (2016) 1.38
The role of standardized data and terminological systems in computerized clinical decision support systems: literature review and survey. Int J Med Inform (2010) 1.32
Haloperidol prophylaxis in critically ill patients with a high risk for delirium. Crit Care (2013) 1.31
The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys. Blood (2013) 1.26
Hospital mortality is associated with ICU admission time. Intensive Care Med (2010) 1.26
Functional and genetic evidence that the Mal/TIRAP allele variant 180L has been selected by providing protection against septic shock. Proc Natl Acad Sci U S A (2009) 1.25
Reversal of immunoparalysis in humans in vivo: a double-blind, placebo-controlled, randomized pilot study. Am J Respir Crit Care Med (2012) 1.22
External validation of Acute Physiology and Chronic Health Evaluation IV in Dutch intensive care units and comparison with Acute Physiology and Chronic Health Evaluation II and Simplified Acute Physiology Score II. J Crit Care (2010) 1.22
Emphysema and pneumothorax after percutaneous tracheostomy: case reports and an anatomic study. Chest (2004) 1.20
Vascular endothelial growth factor in systemic capillary leak syndrome. Am J Med (2009) 1.19
Tight glycemic control and computerized decision-support systems: a systematic review. Intensive Care Med (2009) 1.19
Teledermatologic consultation and reduction in referrals to dermatologists: a cluster randomized controlled trial. Arch Dermatol (2009) 1.18
Errors associated with applying decision support by suggesting default doses for aminoglycosides. Drug Saf (2006) 1.17
Upregulation of renal inducible nitric oxide synthase during human endotoxemia and sepsis is associated with proximal tubule injury. Clin J Am Soc Nephrol (2006) 1.17
Circulating angiopoietin-2 levels in the course of septic shock: relation with fluid balance, pulmonary dysfunction and mortality. Intensive Care Med (2009) 1.16
Monitoring myeloablative therapy-induced small bowel toxicity by serum citrulline concentration: a comparison with sugar permeability tests. Cancer (2005) 1.14
GTS-21 inhibits pro-inflammatory cytokine release independent of the Toll-like receptor stimulated via a transcriptional mechanism involving JAK2 activation. Biochem Pharmacol (2009) 1.14
Selective iNOS inhibition for the treatment of sepsis-induced acute kidney injury. Nat Rev Nephrol (2009) 1.14
Performance of prognostic models in critically ill cancer patients - a review. Crit Care (2005) 1.13
Implementing quality indicators in intensive care units: exploring barriers to and facilitators of behaviour change. Implement Sci (2010) 1.12
The effect of computerized decision support on barriers to guideline implementation: a qualitative study in outpatient cardiac rehabilitation. Int J Med Inform (2010) 1.12
Hepcidin as a target of therapy in the treatment of anemia after trauma. Crit Care Med (2015) 1.11
Infections in patients with hematological cancer: recent developments. Hematology Am Soc Hematol Educ Program (2003) 1.11
Intestinal damage determines the inflammatory response and early complications in patients receiving conditioning for a stem cell transplantation. PLoS One (2010) 1.11
Acetazolamide-mediated decrease in strong ion difference accounts for the correction of metabolic alkalosis in critically ill patients. Crit Care (2006) 1.10
Implementation of a delirium assessment tool in the ICU can influence haloperidol use. Crit Care (2009) 1.10
Metformin improves survival in intensive care unit patients, but why? Crit Care (2013) 1.09
The furosemide stress test to predict renal function after continuous renal replacement therapy. Crit Care (2014) 1.08
Modulation of innate immunity by adenosine receptor stimulation. Shock (2011) 1.08
Hormone and Cytokine Responses to Repeated Endotoxin Exposures-No Evidence of Endotoxin Tolerance After 5 Weeks in Humans. Shock (2015) 1.08
Effects and costs of home-based training with telemonitoring guidance in low to moderate risk patients entering cardiac rehabilitation: The FIT@Home study. BMC Cardiovasc Disord (2013) 1.07
Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series. BMC Infect Dis (2014) 1.07
Gender-specific differences in outcome after trauma may be explained by differences in immunity. Crit Care (2014) 1.06
Physical exercise for patients undergoing hematopoietic stem cell transplantation: systematic review and meta-analyses of randomized controlled trials. Phys Ther (2012) 1.05